首页> 外文期刊>Journal of Scientific & Industrial Research >Ionotropically-gelled mucoadhesive beads for oral metformin HC1 delivery: Formulation, optimization and antidiabetic evaluation
【24h】

Ionotropically-gelled mucoadhesive beads for oral metformin HC1 delivery: Formulation, optimization and antidiabetic evaluation

机译:口服二甲双胍HC1的离子凝胶粘膜粘附珠:配方,优化和抗糖尿病评估

获取原文
获取原文并翻译 | 示例
       

摘要

The work investigates the development and optimization of ionotropically-gelled mucoadhesive beads composed of tamarind seed polysaccharide (TSP)-alginate polymer-blend for oral delivery of metformin HC1 using 3~2 factorial design. The optimized mucoadhesive beads exhibited 94.86 ± 3.92 % drug encapsulation efficiency and good mucoadhesivity with the biological membrane in wash-off test, and sustained drug release profile over 10 h. The in vitro drug release from these beads was followed controlled-release (zero-order) pattern (R~2 = 0.9873 to 0.9980) with super case-II transport mechanism. The optimized TSP-alginate mucoadhesive beads containing metformin HC1 showed significant antidiabetic effects alloxan-induced diabetic rats over prolonged period after oral administration. These results clearly demonstrated that the developed mucoadhesive beads was found suitable for prolonged systemic absorption of metformin HC1 through sustained drug release and mucoadhesive properties after oral administration in the management of non-insulin dependent diabetes mellitus with maintenance of blood glucose level.
机译:这项工作研究了使用罗望子种子多糖(TSP)-海藻酸酯聚合物混合物制成的离子胶凝型粘膜粘着微珠的开发和优化过程,并采用3〜2因子设计来口服二甲双胍HC1。优化的粘膜粘附珠在冲洗试验中表现出94.86±3.92%的药物包封效率和与生物膜的良好粘膜粘附性,并在10小时内持续释放药物。这些珠的体外药物释放遵循具有超级案例II转运机制的控释(零级)模式(R〜2 = 0.9873至0.9980)。含有二甲双胍HCl的优化的TSP-藻酸盐粘膜粘附珠在口服后的较长时间内显示出明显的抗糖尿病作用,这是四氧嘧啶诱导的糖尿病大鼠的结果。这些结果清楚地表明,在非胰岛素依赖型糖尿病的维持血糖水平的管理中,经口服给药后,通过持续的药物释放和粘膜粘附特性​​,已开发的粘膜粘附珠适合于二甲双胍HCl的全身吸收。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号